SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042991
Filing Date
2019-11-12
Accepted
2019-11-12 16:45:36
Documents
3
Period of Report
2019-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-8k_20191112.htm 8-K 33355
2 EX-99.1 itrm-ex991_73.htm EX-99.1 161048
3 GRAPHIC gfsrbjg1xmlz000001.jpg GRAPHIC 9864
  Complete submission text file 0001564590-19-042991.txt   209406
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 191210303
SIC: 2834 Pharmaceutical Preparations